News
Select Category
| All Entries | New Antibodies | Research News | About antibodies-online.com |
Monoclonal anti-human IgE antibodies: Research tools for allergy research
Area: Allergy
Several new anti-human IgE antibodies for allergy research are now available from antibodies-online.com. Among them are the well published anti-human IgE antibody (SUS-11)
anti-human IgE antibody (BSW17) and
monoclonal anti-human IgE antibody (Le27).
Immunoglobulin E (IgE) and the interaction with it’s receptors expressed on mast cells and basophils are main players in the pathomechanism of IgE mediated allergic reactions (allergic rhinitis, asthma, atopic dermatitis, food allergies). Purified human IgE protein, recombinant IgE receptors and biochemically as well as functionally well characterized monoclonal antibodies directed against different epitopes on these components are tools of central importance for allergy research and diagnostics, but also for the identification and development of novel anti-allergic drugs.
Anti-human IgE (SUS-11) antibody is a highly affinity purified human IgE derived from B cells of healthy donors (no myeloma origin). It is being used in numerous research- and development laboratories for various in vitro and in vivo applications.
Monoclonal anti-human IgE antibody (BSW17) recognizes an epitope spanning across the C3 and C4 domains of human IgE and inhibits the binding of IgE to its high affinity receptor. Apart from classical applications (ELISA, FACS, W-blot), mAb BSW17 is the antibody of choice to study the mechanism of IgE dependent activation of mast cells and basophils. The properties of mAb BSW17 have also been described in a series of international publications.
Monoclonal anti-human IgE antibody (Le27) is optimally suitable for in vitro tests like ELISA, FACS, W-blot. In combination wit human IgE (SUS-11) this mAb is optimally suited for controlled mast cell activation.
A set consisting of all three components offers an ideal basis for the development of customized screening assays and ELISA for the determination of IgE concentrations in human blood samples.
These products are also available as functionally active conjugates with biotin and other standard labels (e.g. AP, FITC, PE) and can also be ordered in azide free buffer for functional tests using living cells. They are delivered with a certificate of analysis documenting purity and target binding. In case of proven quality deficiencies our money-back guarantee applies.
Anti-human IgE (SUS-11) antibody is a highly affinity purified human IgE derived from B cells of healthy donors (no myeloma origin). It is being used in numerous research- and development laboratories for various in vitro and in vivo applications.
Monoclonal anti-human IgE antibody (BSW17) recognizes an epitope spanning across the C3 and C4 domains of human IgE and inhibits the binding of IgE to its high affinity receptor. Apart from classical applications (ELISA, FACS, W-blot), mAb BSW17 is the antibody of choice to study the mechanism of IgE dependent activation of mast cells and basophils. The properties of mAb BSW17 have also been described in a series of international publications.
Monoclonal anti-human IgE antibody (Le27) is optimally suitable for in vitro tests like ELISA, FACS, W-blot. In combination wit human IgE (SUS-11) this mAb is optimally suited for controlled mast cell activation.
A set consisting of all three components offers an ideal basis for the development of customized screening assays and ELISA for the determination of IgE concentrations in human blood samples.
These products are also available as functionally active conjugates with biotin and other standard labels (e.g. AP, FITC, PE) and can also be ordered in azide free buffer for functional tests using living cells. They are delivered with a certificate of analysis documenting purity and target binding. In case of proven quality deficiencies our money-back guarantee applies.
-

04.05.2012 New supplier of ELISA kits -

04.05.2012 Antibodies for pathology -

04.05.2012 1,000 new antibodies from Enogene -

03.05.2012 Cusabio: Many new products, additional protocols and price promotions in May -

18.04.2012 Abgent: Price reduced by 50%! -

18.04.2012 YueerBio: New ELISA kits for food-safety evaluation -

18.04.2012 USCN Life Science (USCNK) ELISA kits: Many new images -

18.04.2012 Cusabio: 49.000 new ELISA kits -

11.04.2012 50% OFF Abgent antibodies until end of April -

03.04.2012 Conference: SMi present their 2nd annual Biobanking: Enabling research by improving access to samples -

02.04.2012 Conference: SMi present their inaugural conference. ADC Summit -

02.04.2012 A Partnering Event will take place in Japan: a gold mine of bio/pharma-related seeds! -

27.03.2012 Conference: SMi present their 15th annual conference on Generics, Supergenerics and Patent Strategies -

27.03.2012 Conference: Fleming Europe following the development of orphan drugs -

01.03.2012 New Detroit R&D products -

01.03.2012 Many new products from Agrisera -

24.11.2011 Selective Antibodies: Detection of psychoactive substances -

24.11.2011 GeneDireX: Novel protein ladders -

09.11.2011 RayBiotech: 10,000 new antibodies -

09.11.2011 Cusabio: New recombinant proteins -

28.10.2011 New Exalpha antibodies -

28.10.2011 Raybiotech: Antibody arrays for multiplex ELISA -

17.10.2011 YO-Proteins offers many new products -

17.10.2011 Biovision: More than 500 novel products -

17.10.2011 Blue Gene: More than 2700 ELISA kits


.jpg)